As on Wednesday, Orchestra BioMed Holdings Inc (NASDAQ: OBIO) got off with the flyer as it spiked 11.19% to $4.67, before settling in for the price of $4.2 at the close. Taking a more long-term approach, OBIO posted a 52-week range of $2.20-$6.30.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -273.68%. Meanwhile, its Annual Earning per share during the time was -273.68%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.04%. This publicly-traded company’s shares outstanding now amounts to $56.46 million, simultaneously with a float of $43.57 million. The organization now has a market capitalization sitting at $263.69 million. At the time of writing, stock’s 50-day Moving Average stood at $3.95, while the 200-day Moving Average is $3.29.
Orchestra BioMed Holdings Inc (OBIO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Orchestra BioMed Holdings Inc’s current insider ownership accounts for 22.84%, in contrast to 40.60% institutional ownership. According to the most recent insider trade that took place on Nov 14 ’25, this organization’s insider bought 5,000 shares at the rate of 4.07, making the entire transaction reach 20,350 in total value, affecting insider ownership by 612,822. Preceding that transaction, on Sep 19 ’25, Company’s Director bought 1,000 for 2.45, making the whole transaction’s value amount to 2,450. This particular insider is now the holder of 108,482 in total.
Orchestra BioMed Holdings Inc (OBIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year. Orchestra BioMed Holdings Inc’s EPS decrease for this current 12-month fiscal period is -5.04% and is forecasted to reach -1.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.80% through the next 5 years, which can be compared against the -273.68% growth it accomplished over the previous five years trading on the market.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Orchestra BioMed Holdings Inc (OBIO). It’s Quick Ratio in the last reported quarter now stands at 4.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 93.51.
In the same vein, OBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.82, a figure that is expected to reach -0.38 in the next quarter, and analysts are predicting that it will be -1.57 at the market close of one year from today.
Technical Analysis of Orchestra BioMed Holdings Inc (OBIO)
Through scrutinizing the latest numbers posted by the [Orchestra BioMed Holdings Inc, OBIO], it can be observed that its last 5-days Average volume of 0.26 million was lower the volume of 0.3 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 14.54% While, its Average True Range was 53.21.
Raw Stochastic average of Orchestra BioMed Holdings Inc (OBIO) in the period of the previous 100 days is set at 76.61%, which indicates a major rise in contrast to 40.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.35 that was higher than 0.24 volatility it exhibited in the past 100-days period.
